2675 — Shenzhen Edge Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$20.51bn
- HK$19.59bn
- CNY455.72m
Annual cashflow statement for Shenzhen Edge Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | fx Preliminary |
| Net Income/Starting Line | -213 | -219 | — |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | -61.8 | 9.44 | — |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -64.5 | -43.8 | — |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -320 | -225 | — |
| Capital Expenditures | -63.6 | -27 | — |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 447 | 223 | — |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 384 | 196 | — |
| Financing Cash Flow Items | -1.8 | -0.376 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -9.18 | -7.34 | — |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 54.5 | -35.5 | — |